PERMANENT AWARD EVIDENCE

Framework for QC Analytical Testing Requirements - AWARD

CPI (Centre for Process Innovation) · published 12 Aug 2025. This page preserves the identifiers and current held fields for one Contracts Finder release; it is not an invoice, performance assessment or complete contract history.

Open official source ↗More from this buyer

Contracts Finder release ID6e48917b-cad4-4b63-ae75-b74e3010f2c7-858621

Open Contracting ID (OCID)ocds-b5fd17-754b8e34-a5b1-42a0-b79d-5434f7aba660

Buyer identifierGB-CFS-224759

Release typeawardUpdate

PUBLISHED COMMERCIAL FIELDS

Values stay separate.

A tender estimate and an award value answer different questions. Neither is treated as cash paid.

Award value: £10,000,000
Tender value: Not disclosed
Procurement method: Open procedure
Category: services
CPV: 71620000
Delivery: Not stated

PUBLISHED DESCRIPTION

What the notice says

You are invited to submit a tender for the following requirements; analytical services for multiple modalities drug substances and drug products required for early phase clinical trials. This tender is to cover the analytical services required for release analysis of drug substance (DS) and drug product (DP).

Tender statuscomplete

STAGE-DATE LEDGER

Reported dates, without an invented lifecycle.

The current projection contains one award release, not a verified chain of planning, tender, award, contract and modification records. Dates are shown in source-field order and are not silently repaired.

01Notice publishedPublication timestamp on the held release12 Aug 2025
02Tender period endsTender-period field as published12 Sept 2024
03Contract startsContract-period field as published24 Apr 2025
04Contract endsContract-period field as published24 Apr 2029

SUPPLIER EVIDENCE

Published names and exact identifiers

A company profile appears only when this release carries a usable company number. Name-only suppliers remain name-only.

Published name only